Catalyst Wire Dossier Catalyst Wire Dossier

Deramiocel

CAP-1002 · Capricor Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Deramiocel, covering 2025-12-17 to 2026-06-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Deramiocel (CAP-1002) in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy [Phase 3]

See pricing